MOS vs TERN · P/E 161, rev $11.12B vs $6.12B cap
The Mosaic Company (MOS) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the MOS and TERN stock pages for the full models.
Not investment advice.